This panel contains the following tests:

• NMR LipoProfile®
• Contains: LDL-P, LDL-C, HDL-C, HDL-P, total cholesterol and triglycerides.
• Provides your ULTRA important LDL particle size and particle count.
• An LP-IR score.
• A helpful particle concentration and size chart which reveals CHD risk.
• C-Reactive Protein (high sensitivity)
• The CRP blood test measures your level of systemic inflammation and is used to evaluate your risk of developing coronary artery disease.
• Myeloperoxidase (MPO)
• MPO is a vascular specific marker that measures your body's response to damage in your artery walls and the subsequent formation of vulnerable plaque which is prone to rupture.
• Oxidized LDL (OxLDL) - LDL cholesterol (the “bad” cholesterol) that has been modified by oxidation, triggering inflammation leading to the formation of plaque in the arteries.

   

  Why should you get your oxidized LDL levels tested? The facts speak for themselves:

  • Individuals with high levels of OxLDL are 4 times more likely to develop metabolic syndrome in the next five years.¹
  • Increased OxLDL levels are associated with the presence of coronary artery disease^2-4
  • Levels of OxLDL increase in a step-wise fashion as the severity of coronary artery disease increases.⁵

Cardiovascular disease is the #1 killer of both men and women in the United States! It is also the leading preventable cause of disability!⁶ If you don’t want to be numbered among these statistics, you’ll need to know whether your endothelial cells have been damaged, if your LDL particle count is dangerously high, or helpfully low, and much more!

Sample Report

Instructions

A 12-14 hour fast is required for this blood test. However, drink plenty of water and take all medications as prescribed.

References

1. Holvoet P et al. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA. 2008; 299: 2287-2293
2. Holvoet P et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2001; 21: 844-848.
3. Nishi K et al. Oxidized LDL in carotid plaques and plasma associates with plaquie instability. Aterioscler. Thromb Basc Biol. 2002; 22: 1649-1654
4. Tsimikas S et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery diseae. N Engl J Med, 2005; 353: 46-57
5. Ehara D et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary sndromes. Circulation, 2001: 103:1955-1960
6. http://www.heart.org/idc/groups/ahamah-public/@wcm/@sop/@smd/documents/downloadable/ucm_480086.pdf